dc.contributor.author | Man, YKS | en_US |
dc.contributor.author | Davies, JA | en_US |
dc.contributor.author | Coughlan, L | en_US |
dc.contributor.author | Pantelidou, C | en_US |
dc.contributor.author | Blazquez-Moreno, A | en_US |
dc.contributor.author | Marshall, JF | en_US |
dc.contributor.author | Parker, AL | en_US |
dc.contributor.author | Hallden, G | en_US |
dc.date.accessioned | 2019-03-11T14:37:37Z | |
dc.date.available | 2017-11-30 | en_US |
dc.date.issued | 2018-02 | en_US |
dc.date.submitted | 2018-11-30T10:51:49.175Z | |
dc.identifier.issn | 1535-7163 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/56038 | |
dc.format.extent | 575 - 587 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | MOLECULAR CANCER THERAPEUTICS | en_US |
dc.title | The Novel Oncolytic Adenoviral Mutant Ad5-3 Delta-A20T Retargeted to alpha v beta 6 Integrins Efficiently Eliminates Pancreatic Cancer Cells | en_US |
dc.type | Article | |
dc.rights.holder | ©2018 American Association for Cancer Research. | |
dc.identifier.doi | 10.1158/1535-7163.MCT-17-0671 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424042700023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 2 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 17 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |